FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225293112> ?p ?o ?g. }

• W4225293112 abstract "Abstract Background The serine protease inhibitor nafamostat has been proposed as a treatment for COVID-19, by inhibiting TMPRSS2-mediated viral cell entry. Nafamostat has been shown to have other, immunomodulatory effects, which may be beneficial for treatment, however animal models of ssRNA virus infection are lacking. In this study, we examined the potential of the dual TLR7/8 agonist R848 to mimic the host response to an ssRNA virus infection and the associated behavioural response. In addition, we evaluated the anti-inflammatory effects of nafamostat in this model. Methods CD-1 mice received an intraperitoneal injection of R848 (200 μg, prepared in DMSO, diluted 1:10 in saline) or diluted DMSO alone, and an intravenous injection of either nafamostat (100 μL, 3 mg/kg in 5% dextrose) or 5% dextrose alone. Sickness behaviour was determined by temperature, food intake, sucrose preference test, open field and forced swim test. Blood and fresh liver, lung and brain were collected 6 h post-challenge to measure markers of peripheral and central inflammation by blood analysis, immunohistochemistry and qPCR. Results R848 induced a robust inflammatory response, as evidenced by increased expression of TNF, IFN-γ, CXCL1 and CXCL10 in the liver, lung and brain, as well as a sickness behaviour phenotype. Exogenous administration of nafamostat suppressed the hepatic inflammatory response, significantly reducing TNF and IFN-γ expression, but had no effect on lung or brain cytokine production. R848 administration depleted circulating leukocytes, which was restored by nafamostat treatment. Conclusions Our data indicate that R848 administration provides a useful model of ssRNA virus infection, which induces inflammation in the periphery and CNS, and virus infection-like illness. In turn, we show that nafamostat has a systemic anti-inflammatory effect in the presence of the TLR7/8 agonist. Therefore, the results indicate that nafamostat has anti-inflammatory actions, beyond its ability to inhibit TMPRSS2, that might potentiate its anti-viral actions in pathologies such as COVID-19." @default.
• W4225293112 created "2022-05-05" @default.
• W4225293112 creator A5020028065 @default.
• W4225293112 creator A5027668886 @default.
• W4225293112 creator A5027890281 @default.
• W4225293112 creator A5054669578 @default.
• W4225293112 creator A5080271134 @default.
• W4225293112 creator A5082580794 @default.
• W4225293112 date "2022-01-06" @default.
• W4225293112 modified "2023-09-29" @default.
• W4225293112 title "Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness" @default.
• W4225293112 cites W1857746659 @default.
• W4225293112 cites W1969072247 @default.
• W4225293112 cites W1970090557 @default.
• W4225293112 cites W1971564068 @default.
• W4225293112 cites W1972776583 @default.
• W4225293112 cites W1977186831 @default.
• W4225293112 cites W1985511683 @default.
• W4225293112 cites W1988940166 @default.
• W4225293112 cites W2006025022 @default.
• W4225293112 cites W2008779800 @default.
• W4225293112 cites W2012968633 @default.
• W4225293112 cites W2016490341 @default.
• W4225293112 cites W2016844885 @default.
• W4225293112 cites W2025098076 @default.
• W4225293112 cites W2026145786 @default.
• W4225293112 cites W2029904937 @default.
• W4225293112 cites W2031045752 @default.
• W4225293112 cites W2031450082 @default.
• W4225293112 cites W2054088423 @default.
• W4225293112 cites W2055369281 @default.
• W4225293112 cites W2058489000 @default.
• W4225293112 cites W2061994498 @default.
• W4225293112 cites W2062835892 @default.
• W4225293112 cites W2068238533 @default.
• W4225293112 cites W2070960650 @default.
• W4225293112 cites W2087685632 @default.
• W4225293112 cites W2098731039 @default.
• W4225293112 cites W2099555137 @default.
• W4225293112 cites W2100656537 @default.
• W4225293112 cites W2117488458 @default.
• W4225293112 cites W2118702564 @default.
• W4225293112 cites W2119388579 @default.
• W4225293112 cites W2129203060 @default.
• W4225293112 cites W2137216702 @default.
• W4225293112 cites W2140387959 @default.
• W4225293112 cites W2141214909 @default.
• W4225293112 cites W2142663422 @default.
• W4225293112 cites W2145426948 @default.
• W4225293112 cites W2162080474 @default.
• W4225293112 cites W2404523827 @default.
• W4225293112 cites W2418013109 @default.
• W4225293112 cites W2467958806 @default.
• W4225293112 cites W2473353627 @default.
• W4225293112 cites W2509449660 @default.
• W4225293112 cites W2529095356 @default.
• W4225293112 cites W2596798372 @default.
• W4225293112 cites W2746854706 @default.
• W4225293112 cites W2791348807 @default.
• W4225293112 cites W2802785142 @default.
• W4225293112 cites W2804395498 @default.
• W4225293112 cites W2811117516 @default.
• W4225293112 cites W2903821735 @default.
• W4225293112 cites W2904597631 @default.
• W4225293112 cites W2931761017 @default.
• W4225293112 cites W2950405741 @default.
• W4225293112 cites W2971944560 @default.
• W4225293112 cites W2980572764 @default.
• W4225293112 cites W2992269340 @default.
• W4225293112 cites W3009912996 @default.
• W4225293112 cites W3014003872 @default.
• W4225293112 cites W3016489853 @default.
• W4225293112 cites W3022047971 @default.
• W4225293112 cites W3023991776 @default.
• W4225293112 cites W3027829318 @default.
• W4225293112 cites W3031330053 @default.
• W4225293112 cites W3033543683 @default.
• W4225293112 cites W3036600966 @default.
• W4225293112 cites W3040993696 @default.
• W4225293112 cites W3041582510 @default.
• W4225293112 cites W3044220214 @default.
• W4225293112 cites W3045079087 @default.
• W4225293112 cites W3046988613 @default.
• W4225293112 cites W3086851366 @default.
• W4225293112 cites W3091914998 @default.
• W4225293112 cites W3096640075 @default.
• W4225293112 cites W3097251028 @default.
• W4225293112 cites W3111010928 @default.
• W4225293112 cites W3119728301 @default.
• W4225293112 cites W3122249035 @default.
• W4225293112 cites W3133989519 @default.
• W4225293112 cites W3134151984 @default.
• W4225293112 cites W3158953228 @default.
• W4225293112 doi "https://doi.org/10.1186/s12974-021-02357-y" @default.
• W4225293112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34991643" @default.
• W4225293112 hasPublicationYear "2022" @default.
• W4225293112 type Work @default.
• W4225293112 citedByCount "10" @default.
• W4225293112 countsByYear W42252931122022 @default.
• W4225293112 countsByYear W42252931122023 @default.

• next